Skip to content

Alpha Cognition ACOG Investing Cash Flow

Investing Cash Flow at other companies

Biogen logo
BiogenBIIB
-$209.5M-343%
AbbVie logo
AbbVieABBV
-$574M+21.9%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
-$52K+61.5%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$66.28M+153%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
-$11.32M+42.9%
uniQure logo
uniQureQURE
$98.56M+390%

Other financials

Income statement

See full
Revenue$3.5M+20.7%
Gross profit$3.3M+12.7%
Operating income-$8.1M-138%
Net income-$6.5M-276%
EPS (diluted)-$0.32-191%

Balance sheet

See full
Cash & equivalents$54.3M+100,638%
Total equity$57.5M+49.2%
Total assets$69.2M+42.5%

Cash flow

See full
Operating cash flow-$11.8M-477%
CapEx$1.3K-97.9%
Free cash flow-$11.8M-460%

Valuation

See full
Market cap$157.21M+6.6%
P/S14.5×

Profitability

See full
Gross margin89.3%
Operating margin-250.1%
Net margin-232.2%
FCF margin-280.5%

Returns & leverage

See full
Return on equity-52.4%-5.3pp
Current ratio12.6×-4.5×

Where this comes from

Reported directly by Alpha Cognition in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Alpha Cognition’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alpha Cognition's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alpha Cognition's investing cash flow?
Alpha Cognition (ACOG) reported investing cash flow of -$1.32K in Q1 2026.
How has Alpha Cognition's investing cash flow changed year-over-year?
Alpha Cognition's investing cash flow increased by 97.9% year-over-year, from -$63.27K to -$1.32K.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.